IP Library › Granted Patent US 8,557,978
Granted Patent B2
US 8,557,978 · App. 13/238,391 · Granted Oct 15, 2013

Cross-linked glycopeptide-cephalosporin antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,978
App. No.
13/238,391
Granted
Oct 15, 2013
Kind
B2
Abstract

This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

Claims (4)

1. A compound of the formula:

or a pharmaceutically-acceptable salt thereof.

2. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of the formula:

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0484 →